• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六氟化硫交换反应作为合成联芳基硫酸酯核心衍生物(强效丙型肝炎病毒NS5A抑制剂)的关键反应及其构效关系研究

Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure-activity relationship studies.

作者信息

You Youngsu, Kim Hee Sun, Park Jung Woo, Keum Gyochang, Jang Sung Key, Kim B Moon

机构信息

Department of Chemistry, College of Natural Sciences, Seoul National University Seoul 08826 South Korea

Division of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology Pohang 37673 South Korea.

出版信息

RSC Adv. 2018 Sep 12;8(55):31803-31821. doi: 10.1039/c8ra05471a. eCollection 2018 Sep 5.

DOI:10.1039/c8ra05471a
PMID:35548241
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9085918/
Abstract

Extremely potent, new hepatitis C virus (HCV) nonstructural 5A (NS5A) featuring substituted biaryl sulfate core structures was designed and synthesized. Based on the previously reported novel HCV NS5A inhibitors featuring biaryl sulfate core structures which exhibit two-digit picomolar half-maximal effective concentration (EC) values against HCV genotype 1b and 2a, the new inhibitors equipped with the sulfate core structures containing diversely substituted aryl groups were explored. In this study, highly efficient, chemoselective coupling reactions between an arylsulfonyl fluoride and an aryl silyl ether, known as the sulfur(vi) fluoride exchange (SuFEx) reaction, were utilized. Among the inhibitors prepared based on the SuFEx chemistry, compounds 14, 15 and 29 exhibited two-digit picomolar EC values against GT-1b and single digit or sub nanomolar activities against the HCV GT-2a strain. Nonsymmetrical inhibitors containing an imidazole and amide moieties on each side of the sulfate core structures were also synthesized. In addition, a biotinylated probe targeting NS5A protein was prepared for labeling using the same synthetic methodology.

摘要

设计并合成了具有取代联芳基硫酸酯核心结构的超强效新型丙型肝炎病毒(HCV)非结构5A(NS5A)。基于先前报道的具有联芳基硫酸酯核心结构的新型HCV NS5A抑制剂,其对HCV 1b型和2a型基因型显示出两位数皮摩尔的半数最大有效浓度(EC)值,探索了配备含有不同取代芳基的硫酸酯核心结构的新型抑制剂。在本研究中,利用了芳基磺酰氟与芳基硅醚之间高效、化学选择性的偶联反应,即硫(VI)氟交换(SuFEx)反应。在基于SuFEx化学制备的抑制剂中,化合物14、15和29对GT-1b显示出两位数皮摩尔的EC值,对HCV GT-2a毒株显示出个位数或亚纳摩尔活性。还合成了在硫酸酯核心结构两侧含有咪唑和酰胺部分的不对称抑制剂。此外,使用相同的合成方法制备了用于标记的靶向NS5A蛋白的生物素化探针。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/6c1a3e7f85cd/c8ra05471a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/3e9f9de87489/c8ra05471a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/128f7bf82fd4/c8ra05471a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/b07e83152adf/c8ra05471a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/d9f260ffab21/c8ra05471a-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/f8e4c7a29227/c8ra05471a-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/6c1a3e7f85cd/c8ra05471a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/3e9f9de87489/c8ra05471a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/128f7bf82fd4/c8ra05471a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/b07e83152adf/c8ra05471a-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/d9f260ffab21/c8ra05471a-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/f8e4c7a29227/c8ra05471a-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a43e/9085918/6c1a3e7f85cd/c8ra05471a-f3.jpg

相似文献

1
Sulfur(vi) fluoride exchange as a key reaction for synthesizing biaryl sulfate core derivatives as potent hepatitis C virus NS5A inhibitors and their structure-activity relationship studies.六氟化硫交换反应作为合成联芳基硫酸酯核心衍生物(强效丙型肝炎病毒NS5A抑制剂)的关键反应及其构效关系研究
RSC Adv. 2018 Sep 12;8(55):31803-31821. doi: 10.1039/c8ra05471a. eCollection 2018 Sep 5.
2
New potent biaryl sulfate-based hepatitis C virus inhibitors.新型强效基于硫酸联芳基的丙型肝炎病毒抑制剂。
Eur J Med Chem. 2017 Jan 5;125:87-100. doi: 10.1016/j.ejmech.2016.09.031. Epub 2016 Sep 10.
3
Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors.新型双咪唑基苯基丁二炔衍生物作为丙型肝炎病毒NS5A抑制剂的设计与合成
Pharmaceuticals (Basel). 2022 May 20;15(5):632. doi: 10.3390/ph15050632.
4
Redesigning of the cap conformation and symmetry of the diphenylethyne core to yield highly potent pan-genotypic NS5A inhibitors with high potency and high resistance barrier.重新设计二苯乙炔核心的帽构象和对称性,以产生高效力和高耐药屏障的泛基因型 NS5A 抑制剂。
Eur J Med Chem. 2022 Feb 5;229:114034. doi: 10.1016/j.ejmech.2021.114034. Epub 2021 Dec 7.
5
Symmetric Anti-HCV Agents: Synthesis, Antiviral Properties, and Conformational Aspects of Core Scaffolds.对称抗丙型肝炎病毒剂:核心支架的合成、抗病毒特性及构象方面
ACS Omega. 2019 Jul 1;4(7):11440-11454. doi: 10.1021/acsomega.9b01242. eCollection 2019 Jul 31.
6
Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir.下一代丙型肝炎病毒NS5A抑制剂比布伦特斯韦的抗病毒活性及耐药性概况
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02558-16. Print 2017 May.
7
Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors.新型对称芴-2,7-二胺衍生物作为强效丙型肝炎病毒抑制剂的设计与合成
Pharmaceuticals (Basel). 2021 Mar 25;14(4):292. doi: 10.3390/ph14040292.
8
Orally bioavailable HCV NS5A inhibitors of unsymmetrical structural class.具有非对称结构类别的口服生物利用度 HCV NS5A 抑制剂。
Bioorg Med Chem Lett. 2020 Sep 1;30(17):127361. doi: 10.1016/j.bmcl.2020.127361. Epub 2020 Jun 20.
9
Evaluation of antiviral effects of novel NS5A inhibitors in hepatitis C virus cell culture system with full-genome infectious clones.评估新型 NS5A 抑制剂在全基因组感染性克隆的丙型肝炎病毒细胞培养系统中的抗病毒效果。
Antiviral Res. 2018 Oct;158:161-170. doi: 10.1016/j.antiviral.2018.08.008. Epub 2018 Aug 15.
10
Comparison of daclatasvir resistance barriers on NS5A from hepatitis C virus genotypes 1 to 6: implications for cross-genotype activity.丙型肝炎病毒1至6型NS5A上的达卡他韦耐药屏障比较:对跨基因型活性的影响
Antimicrob Agents Chemother. 2014 Sep;58(9):5155-63. doi: 10.1128/AAC.02788-14. Epub 2014 Jun 16.

引用本文的文献

1
New strategies to enhance the efficiency and precision of drug discovery.提高药物研发效率和精准度的新策略。
Front Pharmacol. 2025 Feb 11;16:1550158. doi: 10.3389/fphar.2025.1550158. eCollection 2025.
2
Click Chemistry for Biofunctional Polymers: From Observing to Steering Cell Behavior.用于生物功能聚合物的点击化学:从观察细胞行为到引导细胞行为
Chem Rev. 2024 Dec 11;124(23):13216-13300. doi: 10.1021/acs.chemrev.4c00251. Epub 2024 Dec 2.
3
Sulfur fluoride exchange.硫氟交换

本文引用的文献

1
Highlights of the Structure-Activity Relationships of Benzimidazole Linked Pyrrolidines Leading to the Discovery of the Hepatitis C Virus NS5A Inhibitor Pibrentasvir (ABT-530).亮点:苯并咪唑连接吡咯烷结构-活性关系,导致丙型肝炎病毒 NS5A 抑制剂 Pibrentasvir(ABT-530)的发现。
J Med Chem. 2018 May 10;61(9):4052-4066. doi: 10.1021/acs.jmedchem.8b00082. Epub 2018 Apr 23.
2
Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity.设计、合成及具有泛基因型活性的含硅 HCV NS5A 抑制剂的鉴定。
Eur J Med Chem. 2018 Mar 25;148:95-105. doi: 10.1016/j.ejmech.2018.02.025. Epub 2018 Feb 10.
3
Nat Rev Methods Primers. 2023;3. Epub 2023 Aug 3.
4
Sulfur(VI) Fluoride Exchange Chemistry in Solid-Phase Synthesis of Compound Arrays: Discovery of Histone Deacetylase Inhibitors.化合物阵列固相合成中的六氟化硫交换化学:组蛋白去乙酰化酶抑制剂的发现
JACS Au. 2024 Apr 17;4(5):1854-1862. doi: 10.1021/jacsau.4c00042. eCollection 2024 May 27.
5
Synthesis of esters and amides of 2-aryl-1-hydroxy-4-methyl-1H-imidazole-5-carboxylic acids and study of their antiviral activity against orthopoxviruses.2-芳基-1-羟基-4-甲基-1H-咪唑-5-羧酸酯和酰胺的合成及其抗正痘病毒活性的研究。
Bioorg Med Chem Lett. 2023 Jan 1;79:129080. doi: 10.1016/j.bmcl.2022.129080. Epub 2022 Nov 19.
6
Sulfur(VI) Fluoride Exchange (SuFEx)-Mediated Synthesis of the Chitosan-PEG Conjugate and Its Supramolecular Hydrogels for Protein Delivery.六氟化硫交换(SuFEx)介导的壳聚糖-聚乙二醇共轭物的合成及其用于蛋白质递送的超分子水凝胶
Nanomaterials (Basel). 2021 Jan 27;11(2):318. doi: 10.3390/nano11020318.
Sofosbuvir/Velpatasvir/Voxilaprevir: A Pan-Genotypic Direct-Acting Antiviral Combination for Hepatitis C.
索磷布韦/维帕他韦/伏西瑞韦:一种用于丙型肝炎的泛基因型直接抗病毒联合疗法
Ann Pharmacother. 2018 Apr;52(4):352-363. doi: 10.1177/1060028017741508. Epub 2017 Nov 8.
4
Bifluoride-catalysed sulfur(VI) fluoride exchange reaction for the synthesis of polysulfates and polysulfonates.双氟化物催化的硫(VI)氟交换反应在多硫酸盐和多磺酸盐合成中的应用。
Nat Chem. 2017 Nov;9(11):1083-1088. doi: 10.1038/nchem.2796. Epub 2017 Jun 19.
5
Sulfonyl fluorides as privileged warheads in chemical biology.磺酰氟作为化学生物学中具有优势的弹头。
Chem Sci. 2015 May 1;6(5):2650-2659. doi: 10.1039/c5sc00408j. Epub 2015 Mar 16.
6
Direct Acting Anti-hepatitis C Virus Drugs: Clinical Pharmacology and Future Direction.直接作用抗丙型肝炎病毒药物:临床药理学与未来方向。
J Transl Int Med. 2017 Mar 31;5(1):8-17. doi: 10.1515/jtim-2017-0007. eCollection 2017 Mar.
7
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs forSubstance Abuse.奥比他韦/帕利瑞韦/利托那韦与达沙布韦:抗逆转录病毒药物和物质滥用药物的药物相互作用。
Clin Pharmacol Drug Dev. 2017 Mar;6(2):201-205. doi: 10.1002/cpdd.327.
8
Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir.下一代丙型肝炎病毒NS5A抑制剂比布伦特斯韦的抗病毒活性及耐药性概况
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02558-16. Print 2017 May.
9
Preclinical Pharmacokinetics and First-in-Human Pharmacokinetics, Safety, and Tolerability of Velpatasvir, a Pangenotypic Hepatitis C Virus NS5A Inhibitor, in Healthy Subjects.泛基因型丙型肝炎病毒NS5A抑制剂维帕他韦在健康受试者中的临床前药代动力学及首次人体药代动力学、安全性和耐受性研究
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02084-16. Print 2017 May.
10
SuFEx: a metal-free click ligation for multivalent biomolecules.SuFEx:一种用于多价生物分子的无金属点击连接反应。
Org Biomol Chem. 2017 Feb 21;15(7):1549-1553. doi: 10.1039/c6ob02458k. Epub 2017 Jan 24.